Cuba's achievement on a vaccine against lung cancer is a fact, scientist said

It is the CimaVax EGF vaccine being produced at the Cuban Center of Molecular Immunology since the early 1990s.

Cuban scientist Dr. Gisela Gonzalez says she and her team have created a lung cancer vaccine that extends patient's lives.

Dr. Gisela Gonzalez has spent years researching the vaccine which the Cuban government approved for the use of the general public last year.

She says all those years of hard work have finally paid off as trials show that Cubans with lung cancer are living a little longer after having the vaccine.

"One of my early patients was a 32-year-old man when he started taking the vaccine. I had a son that age," the scientist told CNN.

"Now he's 35. He's living and working. He visited us the other day and said he's thinking about having kids."

Gonzalez says that more than 700 patients have received the vaccine over the years, many of them in seven clinical trials in Cuba, Canada and the UK.

More than 400 advanced lung cancer patients received the Vaccine CimaVax EGF in the trials, according to the Latin American News Agency.

Source: CNN